Suchergebnisse - (Subject:"2019-nCoV")

PubPharm (395)

1

Serum and Salivary IgG and IgA Response After COVID-19 Messenger RNA Vaccination

enthalten in: JAMA network open | 2024

von Gorochov, G. | Ropers, J. | Launay, O. | +32

2

Safety of Ancestral Monovalent BNT162b2, mRNA-1273, and NVX-CoV2373 COVID-19 Vaccines in US Children Aged 6 Months to 17 Years

enthalten in: JAMA network open | 2024

von Hu, M. | Shoaibi, A. | Feng, Y. | +23

3

Stroke Risk After COVID-19 Bivalent Vaccination Among US Older Adults

enthalten in: JAMA | 2024

von Lu, Y. | Matuska, K. | Nadimpalli, G. | +9

CommentIn: JAMA. 2024 Mar 19;331(11):915-917. - PMID 38502085

4

Cardiac side effects of RNA-based SARS-CoV-2 vaccines : Hidden cardiotoxic effects of mRNA-1273 and BNT162b2 on ventricular myocyte function and structure

enthalten in: British journal of pharmacology | 2024

von Schreckenberg, R. | Woitasky, N. | Itani, N. | +3

5

Profiling antibody epitopes induced by mRNA-1273 vaccination and boosters

enthalten in: Frontiers in immunology | 2024

von Girard, B. | Baum-Jones, E. | Best, R. | +15

6

Sustained S-IgG and S-IgA antibodies to Moderna's mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

enthalten in: Frontiers in immunology | 2024

von Serwanga, J. | Ankunda, V. | Katende, J. | +16

7

Interim analysis of a phase 1 randomized clinical trial on the safety and immunogenicity of the mRNA-1283 SARS-CoV-2 vaccine in adults

enthalten in: Human vaccines & immunotherapeutics | 2023

von Yassini, P. | Hutchens, M. | Paila, Y. | +4

8

Effectiveness of Monovalent mRNA Vaccines Against Omicron XBB Infection in Singaporean Children Younger Than 5 Years

enthalten in: JAMA pediatrics | 2023

von Wee, L. | Tang, N. | Pang, D. | +7

9

Effects of COVID-19 vaccination and previous SARS-CoV-2 infection on omicron infection and severe outcomes in children under 12 years of age in the USA : an observational cohort study

enthalten in: The Lancet. Infectious diseases | 2023

von Lin, D. | Xu, Y. | Gu, Y. | +5

10

Immunogenicity and reactogenicity of a first booster with BNT162b2 or full-dose mRNA-1273 : A randomised VACCELERATE trial in adults ≥75 years (EU-COVAT-1)

enthalten in: Vaccine | 2023

von Neuhann, J. | Stemler, J. | Carcas, A. | +25

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[40]